$17,200.00
In Stock
Maviret is intended for the treatment of chronic hepatitis C in adults and children over 12 years of age.
The drug Maviret is a combination of two pangenotypic direct-acting antiviral agents in fixed doses – glecaprsvir and pibrentasvir, affecting various stages of the life cycle of the hepatitis C virus of all major genotypes.
Active ingredients: glecaprsvir and pibrentasvir
Prescription medicine
